Clinical trials
Phase 2 Atrial Fibrillation trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Advanz Pharma | 2 |
| AstraZeneca | 2 |
| Bayer | 2 |
| ARCA Biopharma, Inc. | 1 |
| Acesion Pharma | 1 |
| Astellas Pharma Inc | 1 |
| Boehringer Ingelheim | 1 |
| Gilead Sciences | 1 |
| GlaxoSmithKline | 1 |
| InCarda Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 19 |
| Stroke | 3 |
| Atrial Flutter | 2 |
| Arrhythmias, Cardiac | 1 |
| Cerebral Hemorrhage | 1 |
| Heart Failure | 1 |
| Ischemic Attack, Transient | 1 |
| Thromboembolism | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.